A detailed history of Mendel Money Management transactions in Pfizer Inc stock. As of the latest transaction made, Mendel Money Management holds 18,432 shares of PFE stock, worth $514,805. This represents 0.24% of its overall portfolio holdings.

Number of Shares
18,432
Previous 12,652 45.68%
Holding current value
$514,805
Previous $364,000 40.38%
% of portfolio
0.24%
Previous 0.18%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$25.89 - $29.73 $149,644 - $171,839
5,780 Added 45.68%
18,432 $511,000
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $330,596 - $429,408
12,652 New
12,652 $364,000
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $15,563 - $18,192
-485 Reduced 3.24%
14,472 $480,000
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $15,242 - $17,635
-422 Reduced 2.74%
14,957 $548,000
Q1 2023

May 10, 2023

SELL
$39.39 - $51.28 $34,190 - $44,511
-868 Reduced 5.34%
15,379 $627,000
Q4 2022

Feb 13, 2023

SELL
$41.75 - $54.5 $16,491 - $21,527
-395 Reduced 2.37%
16,247 $832,000
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $81,874 - $99,948
1,871 Added 12.67%
16,642 $728,000
Q2 2022

Aug 15, 2022

SELL
$46.53 - $55.17 $83,195 - $98,643
-1,788 Reduced 10.8%
14,771 $774,000
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $408,730 - $506,468
8,934 Added 117.17%
16,559 $857,000
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $57,021 - $84,525
-1,380 Reduced 15.32%
7,625 $450,000
Q3 2021

Nov 09, 2021

BUY
$39.25 - $50.42 $3,728 - $4,789
95 Added 1.07%
9,005 $387,000
Q2 2021

Aug 11, 2021

SELL
$35.91 - $40.68 $2,513 - $2,847
-70 Reduced 0.78%
8,910 $349,000
Q1 2021

May 17, 2021

SELL
$33.49 - $37.77 $24,782 - $27,949
-740 Reduced 7.61%
8,980 $325,000
Q4 2020

Feb 09, 2021

BUY
$33.47 - $42.56 $23,429 - $29,792
700 Added 7.76%
9,720 $358,000
Q3 2020

Nov 10, 2020

SELL
$31.75 - $37.25 $4,762 - $5,587
-150 Reduced 1.64%
9,020 $331,000
Q2 2020

Jul 29, 2020

BUY
$30.12 - $36.54 $12,048 - $14,616
400 Added 4.56%
9,170 $300,000
Q4 2019

Feb 13, 2020

BUY
$32.92 - $37.36 $4,938 - $5,604
150 Added 1.74%
8,770 $344,000
Q3 2019

Nov 08, 2019

SELL
$32.49 - $42.13 $272,591 - $353,470
-8,390 Reduced 49.32%
8,620 $310,000
Q2 2019

Aug 08, 2019

BUY
$36.98 - $41.52 $78,027 - $87,607
2,110 Added 14.16%
17,010 $737,000
Q3 2018

Oct 29, 2018

SELL
$34.47 - $41.81 $249,183 - $302,244
-7,229 Reduced 32.67%
14,900 $657,000
Q4 2017

Feb 06, 2018

BUY
$33.26 - $35.29 $736,010 - $780,932
22,129
22,129 $802,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Mendel Money Management Portfolio

Follow Mendel Money Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mendel Money Management, based on Form 13F filings with the SEC.

News

Stay updated on Mendel Money Management with notifications on news.